ARCHIVES

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Facing Extended Tie Under Acting Director – Maybe

August 19, 1988

NCI FY94 Budget By Mechanism Under House, Senate Mark

September 24, 1993

In Brief: NCI Construction Authority To Continue Under Pane’s Plan: NCAB hearing In Philadelphia

March 11, 1988

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

Adamson Elected Chairman Of Children’s Oncology Group

December 11, 2009

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993